Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Directorate Change

17 Jul 2019 09:00

RNS Number : 7326F
Nationwide Building Society
17 July 2019
 

Date Issued: 17 July 2019

 

 

 

Nationwide Building Society appoints Chris Rhodes as Chief Financial Officer

 

Nationwide Building Society is pleased to announce that Chris Rhodes will succeed Mark Rennison as Chief Financial Officer. He is expected to take up his duties in early Autumn 2019.

 

Chris has served on the Board of Nationwide Building Society, currently as Executive Director Product and Propositions, since April 2009.

 

Commenting on the appointment, Nationwide's Chairman David Roberts said: "I am delighted that Chris Rhodes has agreed to take on the role as Chief Financial Officer, succeeding Mark Rennison. Chris has had a 30 year career in financial services and is an experienced finance director. He has deep understanding of the Society and the mutual business model and through his leadership of product and propositions at Nationwide has placed significant focus on supporting the long term financial stability of the Society and acting in the best interests of our members. Chris commences his role at an exciting time as the Society has embarked upon a substantial investment in technology and he is deeply committed to ensuring the Society continues to invest for the future on behalf of its members."

 

Chris Rhodes said: "I am delighted to have been asked to become Chief Financial Officer of Nationwide Building Society. I intend to ensure Nationwide continues to be a safe home for our members' money whilst investing in products and services which fulfil the needs of our members over the long term. I look forward to building on the work of Mark Rennison and his team."

 

Chris's appointment is subject to regulatory approval.

 

-Ends-

 

For further information, contact:

Sara Batchelor, 07785 344137, sara.batchelor@nationwide.co.uk

 

Notes:

 

Remuneration:

It is expected that the remuneration package of Chris Rhodes will be comparable with that of Mark Rennison, the retiring Chief Financial Officer.

 

Chris Rhodes biography

Chris is a chartered accountant who has spent 30 years in financial services. He spent 20 years at Alliance and Leicester including as Group Finance Director and Acting CEO. He joined Nationwide Building Society in April 2009 and has led Retail and Product and Propositions in his 10 years.

 

Chris has significant experience with industry trade bodies including UK Finance and working closely with government and regulators. He is a former Board Director of Visa Europe and a founding Trustee of the charity National Numeracy.

 

Chris is married with two grown up daughters and he is a keen cyclist.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOASFSFLMFUSEEW
Date   Source Headline
9th Jul 20264:10 pmRNSPublication of Final Terms
9th Jul 20264:04 pmRNSPublication of Final Terms
7th Jul 202612:01 pmRNSNotice of Result of Bondholder Meeting
30th Jun 20264:30 pmRNSAnnual Report - Nationwide Covered Bonds LLP
30th Jun 20261:04 pmRNSAdmission to Trading
26th Jun 20261:52 pmRNSPublication of Final Terms
25th Jun 202612:21 pmRNSAdmission to Trading
23rd Jun 202612:03 pmRNSPublication of Final Terms
23rd Jun 202611:04 amRNSAdmission to Trading
19th Jun 20264:43 pmRNSPublication of Final Terms
15th Jun 20261:30 pmRNSNotice to Covered Bondholders
15th Jun 202612:40 pmRNSPublication of a Supplementary Prospectus
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.